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of hepatic steatosis: Urgent need for standardization!To the Editor:
We read with great interest the study by McPherson
and colleagues [6] that evaluated the accuracy of mag-
netic resonance spectroscopy (MRS) and imaging
(MRI) for grading the severity of hepatic steatosis. In
their study, the authors concluded that, using histology
as a reference standard, MRS and MRI gave an accurate
evaluation of the severity of steatosis, provided that the
stage of ﬁbrosis was considered. Our concerns regarding
this study and its conclusion are outlined as follows.
The lipid fraction measured using MRS and MRI
represents the signal derived from protons contained
in fatty acid molecules which contain a variety of func-
tional groups (methene, diallylic, a-methylene to car-
boxyl, allylic, methylene, and methyl (CH3)) [3].
Methylene (CH2) is the most abundant group in triglyc-
erides and thus, the most commonly used for fat quan-
tiﬁcation with MRS. In this paper like in several
others performed at 1.5 T or less, MRS was performed
using the signal from CH2 + CH3, probably because of
the relatively low spectral resolution at such ﬁeld
strengths and the inability to accurately separate CH2
from CH3 peaks. In our experience, with a 3.0-T MR
system, the CH3 signal can represent up to 15% of the
signal derived from CH2, which could explain substan-
tial diﬀerences according to the method used. Since Dix-
on techniques (in-phase and out-of-phase imaging) were
developed to speciﬁcally oppose the signal derived from
water and that from CH2, the use of CH2 + CH3 for
MRS and CH2 for MRI is illogical in this paper which
compares both MRS and MRI with histological grading
of steatosis. However, to date nothing has been recom-
mended in the literature regarding this issue.
With MRS, the peak area is proportional to the con-
centration of the metabolite containing the relevant nu-
clei, but is also inﬂuenced by T 1 and T 2 relaxation
times [3,4]. Since (1) the T 2 of water andCH2 exhibit con-
siderable interindividual variability [4], (2) iron overload
greatly decreases the T 2 of water and (3) ﬁbrosis signiﬁ-
cantly increases the T 2 of water [5], quantiﬁcation of ste-
atosis using MRS must be corrected for T 2 decay to give
reliable results. Unfortunately, in theMRS protocol used
in this study and described in another paper by the same
authors [1], no correction for T 2 decay was performed.Several spectra should have been acquired with diﬀerent
echo times to correct for T 2 decay via exponential regres-
sion analysis of the peak amplitudes at each echo time.
Consequently, the absence of correction of T 2 decay is
likely to explain the inﬂuence of ﬁbrosis on the correla-
tion between MRS and histology.
With MRI, in-phase and out-of-phase images (Dixon
IP/OP) are not reliable for quantiﬁcation of liver fat in
the case of liver iron overload, which can be present in
many chronic liver diseases including hepatitis C,
NAFLD, cirrhosis, and hemochromatosis [7]. The
shortening of T 2* relaxation time largely explains the
erroneous determination by Dixon IP/OP. The authors
acknowledged this issue and addressed this point by
assessing hepatic iron loading on liver biopsy. To our
knowledge, an easier and more practical approach
would have been to use triple- or multi-echo techniques
derived from Dixon IP/OP, which, in correcting for the
inﬂuence of T 2* decay, proved to provide reliable
results even in the case of iron overload [4,8]. Nowa-
days, these sequences should replace classical Dixon
IP/OP for the determination of liver fat content.
In conclusion, there is an urgent need for the stan-
dardisation of MRS and MRI. It should improve qual-
ity, reproducibility and comparability of their results,
and it would also strongly encourage the mentioning
of the main acquisition parameters and the method for
data analysis, even in clinical papers.
Finally, the question should be raised whether the
visual grading of steatosis using histology is actually
the best reference standard. Given the semi-quantitative
nature of histological grading, its inter-observer variabil-
ity, its overestimation of the degree of steatosis [2], and
the small quantity of liver tissue examined (about 50–
100 mg in a typical biopsy sample vs. 8–27 g in a voxel
of MRS) leading to a sampling bias especially when fat
is heterogeneously distributed throughout the liver
[3,4], would MRS not be a more appropriate choice?
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Combined approach for non-invasive measurement
of liver pathology by MR
To the Editor:
We welcome the response from Guiu et al. regarding
our recently published study [1]. We fully agree that for
MR methods to become a clinical tool, standardization
of the techniques is required. Our results were obtained
at 1.5 T, which remains the predominant clinical MRI
system. The authors fully recognise that there will be
beneﬁts in using 3 T, but the aim of this paper was to
present results that are relevant to the broader clinical
community.
The lack of a true “gold standard” is a potential lim-
iting factor for assessing the potential of new methods.
The latter point has been recently discussed in an edito-
rial and several articles in this Journal (vol. 50, 2009)
earlier this year. In the absence of a true “gold standard”
our analysis is based on clinically accepted measures,
scored by a single expert in liver histopathology (co-
author A.C.). MRS is not a clinically accepted measure.
We intentionally used the combined peak intensity
from CH2 + CH3 in the spectra, as we argue that the
CH3 signal contributes to the lipid fraction in both
imaging methods. The Dixon method uses TE values
that result in the water and CH2 protons being p radians
out-of-phase, based on the frequency shift between the
protons. The small frequency diﬀerence between CH2
and CH3 protons, results in the CH3 spins being almost
out-of-phase and so also contributes to the net lipid sig-
nal. Given the separation of the CH2 and CH3 is only
0.4 ppm, (25.5 Hz at 1.5 T), the fat saturation methods
cannot suppress only CH2 protons, but also signiﬁcantly
suppress the CH3 signal.
Cirrhosis can be associated with increased liver iron
[2]. We suggest caution in assuming that liver ﬁbrosis
universally increases T2, particularly as increased iron
decreases T2.
The conclusions presented are consistent with the dif-
ference in scoring lipid content by the two methods. MR
methods measure lipid fraction per unit volume, irre-
spective of the hepatocyte count in the volume. The his-
tology method scores lipid content as hepatocytes with
visible fat. The number of hepatocyte nuclei per unit
volume decreased with ﬁbrosis, consistent with reduced
hepatocytes per unit volume with ﬁbrosis.
In conclusion, a combined approach should be the
goal for non-invasive measurement of liver pathology
by MR. Lipid content or ﬁbrosis are unlikely to be
universally measured in isolation, particularly without
a measure of iron content. However, with a combination
of lipid selective imaging, relaxometry, diﬀusion, spec-
troscopy and elastography, the future looks promising.
Letters to the Editor / Journal of Hepatology 51 (2009) 1082–1090 1083
